Antibody drug conjugates (ADCs) mark a new era in targeted cancer therapy, delivering potent cytotoxic chemotherapy via monoclonal antibodies directly into the tumor cells — an era with potentially ...

After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...

The athlete's impact during the 2025 season earned him All-Big 12 Third Team honors. This also cemented his role as the centerpiece of the Wildcats’ receiving corps. Brown’s final season in purple ...

On December 16th, Jayce Brown announced his intention to enter the transfer portal. Sources: Kansas State's leading wide receiver, Jayce Brown, intends to enter the NCAA transfer portal. He led the ...

Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...

MANHATTAN — Kansas State football is set to lose its leading wide receiver from the 2025 season, leaving a big hole for Collin Klein as he looks to rebuild the Wildcats' offense. Jayce Brown intends ...

Kansas State will lose top receiver Jayce Brown to the transfer portal. Brown caught 41 passes for 712 yards and five touchdowns while injured. Klein and staff face a major replacement task with ...

HOLYOKE – Hitting one buzzer-beater is cool, but two? That’s even better. For Putnam Tech boys basketball freshman Jayce Johnson, hitting those kinds of shots is easy in the most humble way. “I don’t ...

MANHATTAN — With Jayce Brown set to enter the transfer portal, it's more clear than ever that Kansas State football's most significant need heading into another wave of offseason recruiting will be at ...